For: | Montegiove N, Calzoni E, Emiliani C, Cesaretti A. Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases. JFB 2022;13:125. [DOI: 10.3390/jfb13030125] [Cited by in F6Publishing: 1] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Vohra M, Amir M, Sharma A, Wadhwa S. FORMULATION STRATEGIES FOR NOSE-TO-BRAIN DRUG DELIVERY IN ALZHEIMER'S DISEASE. Health Sciences Review 2023. [DOI: 10.1016/j.hsr.2023.100075] [Reference Citation Analysis] |
2 | Wang Y, Yu DG, Liu Y, Liu YN. Progress of Electrospun Nanofibrous Carriers for Modifications to Drug Release Profiles. J Funct Biomater 2022;13. [PMID: 36547549 DOI: 10.3390/jfb13040289] [Reference Citation Analysis] |
3 | Maeng J, Lee K. Systemic and brain delivery of antidiabetic peptides through nasal administration using cell-penetrating peptides. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1068495] [Reference Citation Analysis] |